ICYMI: GameStop, Omeros, Congress Impacts Biotechs
With GameStop Corp reporting its Q4 results next week, analysts at Loop Capital took a look at how the company might turn a few heads this year under the helm of its new CEO. Learn more, in Bill Haddad's " Analyst Says GameStop's Turnaround Strategy, Share Buybacks Could Alleviate 'Depressed' Valuation ."
from Biotech News
0 Comments